Skip to main content
logo
LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
7.78
-0.21 (-2.63%)
At close: May 29, 2026, 4:00 PM EDT
8.02
+0.24 (3.08%)
After-hours: May 29, 2026, 7:56 PM EDT

LENZ Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
20.9919.09----
Cost of Revenue
1.490.42----
Gross Profit
19.518.67----
Selling, General & Admin
124.9991.1428.8112.9332.8522.51
Research & Development
12.8518.6729.859.572.7937.93
Total Operating Expenses
137.84109.8158.6172.43105.6460.44
Operating Income
-118.34-91.14-58.61-72.43-105.64-60.44
Interest Income
10.089.768.552.194.590.02
Other Non-Operating Income (Expense)
-0.23-0.240.290.09--10.34
Total Non-Operating Income (Expense)
9.859.518.842.284.59-10.32
Pretax Income
-67.01-81.63-49.77-70.15-101.05-70.76
Provision for Income Taxes
0.50.50-0.18--
Net Income
-109-82.13-49.77-69.97-101.05-70.76
Net Income to Common
-109-82.13-49.77-69.97-101.05-70.76
Shares Outstanding (Basic)
302921444
Shares Outstanding (Diluted)
302921444
Shares Change (YoY)
10.43%35.39%415.11%--1166.12%
EPS (Basic)
-3.60-2.85-2.34-35.71-24.46-17.15
EPS (Diluted)
-3.60-2.85-2.34-35.71-24.46-17.15
Shares Outstanding
31.3531.3427.522.528.328.29
Free Cash Flow
-87.44-70-59.86-60.41-94.57-58.59
Free Cash Flow Per Share
-2.94-2.43-2.81-14.62-22.89-14.18
Gross Margin
92.88%97.81%----
Operating Margin
-563.83%-477.46%----
Profit Margin
-519.30%-430.25%----
FCF Margin
-416.59%-366.71%----
EBITDA
-117.98-90.85-58.55-72.41-103.29-59.71
EBITDA Margin
-562.10%-475.96%----
EBIT
-118.34-91.14-58.61-72.43-105.64-60.44
EBIT Margin
-563.83%-477.46%----
Effective Tax Rate
-0.75%-0.62%-0.00%0.26%0.00%0.00%
SEC Filings: 10-K · 10-Q